en · de · es · fr · pt
ghk-cu-notes.peptides5388.com › Wiki › Peptide Identity And Copper Binding — Practical Notes

Peptide Identity And Copper Binding — Practical Notes

By Editorial Desk · published 2025-12-02 · last reviewed 2026-01-21 · Wiki

Gly-His-Lys comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Last reviewed on 2026-01-21. Where a claim depends on a specific study, the study is described rather than over-claimed.

Peptide Identity and Copper Binding

GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-lysine and a copper(II) ion. The peptide sequence is conventionally written as Gly-His-Lys, abbreviated GHK. Copper binds through the imidazole nitrogen of histidine, the alpha-amino group, and a deprotonated amide nitrogen, producing a square-planar geometry. The complex carries a net positive charge near physiological pH and is intensely blue in aqueous solution. The metal-free peptide is often written simply as GHK, while the copper-bound form is written GHK-Cu.

The compound was first isolated from human plasma by the biochemist Loren Pickart in 1973. Early work identified it as a factor that altered the behavior of cultured liver cells, and later studies linked it to connective tissue and wound-related processes. Reported plasma concentrations fall markedly between roughly age twenty and age sixty, a pattern that generated interest in copper peptide biology. Whether that decline has functional consequences remains an open question, because differences observed across age groups do not by themselves establish causation. Research interest later expanded into cosmetic and tissue-culture settings.

Stability, Storage, and Analytical Control

Identity and purity are commonly assessed by reversed-phase high-performance liquid chromatography, frequently paired with mass spectrometry to confirm the molecular ion. Copper content is measured separately, typically by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy, because the chromatographic signal reports the peptide rather than the metal. Ultraviolet-visible spectroscopy provides a fast check on complex formation, since copper(II) peptide complexes absorb in the visible region. Elemental analysis and amino acid analysis are used less often but remain useful for reference standards. A gap between reported peptide purity and measured copper content is a recurring source of confusion.

Material described as GHK-Cu appears in several distinct markets, including cosmetic ingredients, laboratory reagents, and consumer products, and the quality expectations attached to each differ. A certificate of analysis generally reports peptide purity by chromatography, copper content, appearance, and residual solvents or counterions. Counterion identity matters, because the complex is usually supplied as an acetate or a similar salt, and the counterion contributes to the measured mass. Independent verification of sequence and metal stoichiometry is advisable when a material is used for quantitative work. Batch-to-batch variation is common and should be documented rather than assumed negligible.

Ghk-cu at a glance

PropertyValueNotes
Molecular formulaC14H22CuN6O4 as the complexFree peptide is C14H24N6O4
Molecular weightAbout 402 g/molFree peptide is about 340 g/mol
AppearanceBlue solid or blue solutionColor from copper d-d transitions
Solubility classWater-soluble; poor in nonpolar solventsIonic character favors aqueous media
Common synonymsCopper tripeptide-1; glycyl-L-histidyl-L-lysine copperINCI listing uses copper tripeptide-1

Molecular Identity and Discovery Background

The International Nomenclature of Cosmetic Ingredients lists the substance as copper tripeptide-1, the name that appears on most topical product labels. Related designations include copper peptide and GHK-Cu, and the hyphenated form is common in research literature. In cosmetics the material is regulated as an ingredient rather than as a drug, so products may reach the market without evidence of the effects claimed for them. Whether those effects are clinically meaningful is an open question, since most supportive data come from laboratory work and small trials.

GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence found naturally in human plasma, saliva and urine. Loren Pickart reported the isolation of the free peptide in 1973 while studying factors that influenced the growth of aged liver cells in culture. The peptide was later shown to bind copper(II) with high affinity, and the metal-bound form became the focus of most subsequent research. Its concentration in circulation declines markedly with age, a pattern that is well documented, though the physiological consequences of that decline remain debated.

The peptide portion consists of three amino acids: glycine, histidine and lysine. Copper(II) coordinates through the imidazole nitrogen of histidine, the alpha-amino group of glycine and a deprotonated amide nitrogen of the backbone, producing a roughly square-planar geometry. This arrangement gives the complex its characteristic blue-to-violet colour and helps it resist dissociation in water. Reported stability constants are high, although values differ between studies because of differences in ionic strength and measurement method.

Related pages on this site

Stability, Handling, and Analytical Verification

Dry material is normally held cold, commonly at -20 °C for long-term storage and 2 to 8 °C for working quantities, protected from light and moisture. Vials should be allowed to reach room temperature before opening so that condensation does not form on the powder. In liquid formulations the complex is generally kept near neutral to slightly acidic pH, because strongly alkaline conditions favour precipitation of copper hydroxide. Antioxidants or chelate-stabilising excipients are often added, though the specific approaches are proprietary and rarely published in detail.

Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry to confirm the expected mass. Copper content is measured separately by inductively coupled plasma optical emission spectrometry or atomic absorption spectroscopy, because the peptide assay alone does not establish the metal-to-peptide ratio. Visible spectroscopy provides a rapid check on complex integrity through the absorption band in the visible region. Agreement between the peptide assay and the copper assay is the practical test of whether a sample is the intended complex rather than a mixture.

Supporting material

=== Pharmacokinetics === Topical hydrocortisone has minimal absorption into the body: Only 4-19% of the topical hydrocortisone cream applied would be absorbed into the human bloodstream. After a certain extent of absorption, it undergoes distribution, metabolism and elimination pathways that are similar to systemic hydrocortisone. Regarding the distribution of topical hydrocortisone, it binds to plasma proteins such as globulin and albumin, then the drug is mainly metabolized in the liver, and the metabolite will be excreted through bile or by kidneys.

=== Hormone replacement therapy === The doses of hormone replacement therapy (HRT) for CAIS individuals are debatable. Some have hypothesized that supraphysiological levels of estrogen may reduce the diminished bone mineral density associated with CAIS, while counter-arguments suggested a lower dose of HRT because levels of estrogen in CAIS individuals are normally below the female range before gonadectomy. Data has been published that suggests affected women who were not compliant with estrogen replacement therapy, or who had a lapse in estrogen replacement, experienced a more significant loss of bone mineral density. Progestin replacement therapy is usually seldom initiated as well. Androgen replacement has been reported to increase a sense of well-being in gonadectomized people with CAIS, although the mechanism by which this benefit is achieved is not well understood.

Molecular machines are a class of molecules typically described as an assembly of a discrete number of molecular components intended to produce mechanical movements in response to specific stimuli, mimicking macromolecular devices such as switches and motors. Naturally occurring or biological molecular machines are responsible for vital living processes such as DNA replication and ATP synthesis. Kinesins and ribosomes are examples of molecular machines, and they often take the form of multi-protein complexes. Multiple examples of molecular machinery and their components are found in the Protein Data Bank. For the last several decades, scientists have attempted, with varying degrees of success, to miniaturize machines found in the macroscopic world. The first example of an artificial molecular machine (AMM) was reported in 1994, featuring a rotaxane with a ring and two different possible binding sites. In 2016 the Nobel Prize in Chemistry was awarded to Jean-Pierre Sauvage, Sir J. Fraser Stoddart, and Bernard L. Feringa for the design and synthesis of molecular machines. A major point is to exploit existing motion in proteins, such as rotation about single bonds or cis-trans isomerization. Different AMMs are produced by introducing various functionalities, such as the introduction of bistability to create switches. A broad range of AMMs has been designed, featuring different properties and applications; some of these include molecular motors, switches, and logic gates.

12 June – The ONS reports that the UK economy failed to grow during April. The zero percent growth rate is attributed to unusually high rainfall, well above the long-term average, which impacted consumer spending. 13 June Keir Starmer unveils the Labour Party's general election manifesto. He says that wealth creation is the "number one priority" and that Labour will focus on economic growth. The first commercial-scale liquid air energy storage plant begins development in Carrington, Greater Manchester. Its backers say the £300m facility will create more than 700 jobs and have the capacity to power 480,000 homes. 14 June Tesco reports a 5% increase in sales over the past three months, and says that consumer confidence is beginning to return. Manufacturers are recalling several types of prepacked sandwiches, wraps and salads from major supermarkets amid concerns they could be contaminated with E. coli. Nigel Farage says he is "leader of the opposition" after a YouGov poll shows Reform UK ahead of the Conservative Party for the first time. Rishi Sunak responds by saying that Labour would be handed a "blank cheque" if current polling were replicated at the general election. It is confirmed that the Princess of Wales will attend the 2024 Trooping the Colour ceremony, making her first public appearance since her cancer diagnosis. The 2024 Birthday Honours are released, with those recognised including Alan Bates, the postmaster whose campaign brought the Post Office scandal to public attention.

Sources: en.wikipedia.org

Supporting material

The principal goal of the fat acceptance movement is to decrease discrimination against people who are overweight and obese. However, some in the movement are also attempting to challenge the established relationship between obesity and negative health outcomes. A number of organizations exist that promote the acceptance of obesity. They have increased in prominence in the latter half of the 20th century. The US-based National Association to Advance Fat Acceptance (NAAFA) was formed in 1969 and describes itself as a civil rights organization dedicated to ending size discrimination. The International Size Acceptance Association (ISAA) is a non-governmental organization (NGO) which was founded in 1997. It has more of a global orientation and describes its mission as promoting size acceptance and helping to end weight-based discrimination. These groups often argue for the recognition of obesity as a disability under the US Americans With Disabilities Act (ADA). The American legal system, however, has decided that the potential public health costs exceed the benefits of extending this anti-discrimination law to cover obesity.

The Swedish word riksdag, in definite form riksdagen, is a general term for "parliament" or "assembly", but it is typically only used for Sweden's legislature and certain related institutions. In addition to Sweden's parliament, it is also used for the Parliament of Finland and the Estonian Riigikogu, as well as the historical German Reichstag and the Danish Rigsdagen. In Swedish use, riksdagen is usually not capitalised. Riksdag derives from the genitive of rike, referring to royal power, and dag, meaning diet or conference; the German word Reichstag and the Danish Rigsdag are cognate. The Oxford English Dictionary traces English use of the term "Riksdag" in reference to the Swedish assembly back to 1855.

==== Selenomelanin ==== It is possible to enrich melanin with selenium instead of sulphur. This selenium analogue of pheomelanin has been successfully synthesized through chemical and biosynthetic routes using selenocystine as a feedstock. Due to selenium's higher atomic number, the obtained selenomelanin can be expected to provide better protection against ionising radiation as compared to the other known forms of melanin. This protection has been demonstrated with radiation experiments on human cells and bacteria, opening up the possibility of applications in space travel.

Although prepared to grant formal independence to Southern Rhodesia (now Rhodesia), the British government had adopted a policy of no independence before majority rule (NIBMR), dictating that colonies with a significant, politically active population of European settlers would not receive independence except under conditions of majority rule. White Rhodesians balked at the premise of NIBMR; many felt they had a right to absolute political control, at least for the time being, despite their relatively small numbers. They were also disturbed by the chaos of the post-colonial political transitions occurring in other African nations at the time, such as the Democratic Republic of the Congo. A vocal segment of the white populace was open to the concept of gradually incorporating black Rhodesians into civil society and a more integrated political structure in theory, although not without qualification and equivocation. A greater degree of social and political equality, they argued, was acceptable once more black citizens had obtained higher educational and vocational standards. The second faction in the white community was wholly unwilling to concede the principle, much less the practice, of equality to the black population. Both groups remained opposed to majority rule in the near future. However, once Rhodesia had been introduced as a topic for discussion in international bodies, extension of the status quo became a matter of concern to the British government, which perceived the scrutiny as a serious embarrassment to the United Kingdom.

== Histiocytic sarcoma complex == The histiocytic sarcoma (HS) complex encompasses a number of distinctive clinical entities which will be described below. Some definitions are in order, and reflect the preferred nomenclature of the writing group of the Histiocyte Society. Histiocytic neoplasia which originates at a single site is called histiocytic sarcoma. This form of histiocytic sarcoma, which is often encountered on the extremities, has the best prognosis if treated early by surgical excision or by amputation of a limb. When spread to distant sites beyond the local lymph node occurs, the disease is then termed disseminated histiocytic sarcoma; this is more likely to occur unnoticed when primary lesions occur in cryptic sites (e.g. spleen, lung, and bone marrow). This latter form of HS is most like malignant histiocytosis (MH). MH is an aggressive, histiocytic neoplasm which arises in multiple sites simultaneously. Most lesions previously defined as MH are probably more correctly termed disseminated HS. The occurrence of true MH is difficult to establish because the lesions often occur in cryptic sites, and the existence of histiocytic neoplasia is only recognized after clinical signs have appeared and disease progression is advanced. HS and MH are capable of widespread metastasis, hence in time the 2 syndromes merge clinically and it is not always possible to differentiate true multicentric origin (MH) from widespread metastasis of disseminated HS. Also, it is never possible to know exactly how long the disease process has been operative.

Sources: en.wikipedia.org

Frequently asked questions

What is GHK-Cu chemically?

It is the copper(II) complex of the tripeptide glycyl-L-histidyl-lysine, a sequence of three amino acids. The copper ion is held by the histidine imidazole, the terminal amino group, and an amide nitrogen. The bound form is distinct from the free peptide in charge, color, and stability.

Why is the complex blue?

Copper(II) complexes absorb light in the red part of the visible spectrum, so transmitted light appears blue. The absorption arises from electronic transitions within the copper d-orbitals, which are split by the surrounding ligands. The intensity and exact wavelength shift somewhat with pH, solvent, and ligand arrangement.

Is the peptide active without copper?

The free peptide and the copper-bound complex are studied as separate species and do not always behave the same way in assays. Some reported responses are attributed to copper delivery, while others are attributed to the peptide sequence itself. Which fraction drives a given observation is often unresolved in the published work.

How should GHK-Cu be stored?

The solid is typically held cold and dry, and solutions are kept for shorter periods because hydrolysis proceeds in water. Repeated freeze-thaw cycles are usually avoided, since they can degrade both the peptide and the complex. Container material and headspace also affect how long a sample remains unchanged.

Network